One year later, she presented again with worsening dyspnoea associated with decreased oxygen saturation.
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Because of her co-morbidities, the patient was deemed a poor candidate for surgery. The shunt was closed with a 25 mm patent foramen ovale (PFO) Amplatzer device (Panel E). Postprocedural angiography and TEE confirmed the presence of a well-seated device with no residual shunt (Panel F). Twenty-four hours later, her SpO 2 was 98%. Three months after the final procedure, a transthoracic echocardiogram showed well-seated devices and no interatrial shunting; her SpO 2 was 99%. To the best of our knowledge, this is the first published report of three sequential devices implanted to close recurrent shunting across an ASD.
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